Medical Care Center Gastroenterology Friedrichshain
- Address
- lock Available on a paid plan
Medical Care Center Gastroenterology Friedrichshain
Medical Care Center Gastroenterology Friedrichshain is a specialized gastroenterological research facility dedicated to advancing treatment strategies for inflammatory bowel diseases. The center demonstrates particular expertise in evaluating novel therapeutic approaches for patients with newly diagnosed conditions, focusing on optimizing early intervention strategies to achieve comprehensive disease control.
- Comparative effectiveness studies of biologic therapies versus conventional immunosuppressive treatments
- Top-down treatment strategies in moderate-to-severe ulcerative colitis
- Long-term maintenance therapy optimization and disease control assessment
The center's research emphasizes the evaluation of mirikizumab and other advanced biologics in the management of ulcerative colitis, with a focus on newly diagnosed patients. Their clinical trials investigate comprehensive disease control outcomes, including the efficacy of extended induction protocols and re-induction strategies compared to traditional step-up approaches using azathioprine and glucocorticoids. This research contributes valuable evidence for determining optimal first-line treatment strategies in moderate-to-severe inflammatory bowel disease.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Medical Care Center Gastroenterology Friedrichshain
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Comparative Efficacy of Mirikizumab Versus Azathioprine and Glucocorticoids in Newly Diagnosed Moderate-to-Severe Ulcerative Colitis: A 52-Week Randomized Trial | Universitaetsklinikum Schleswig-Holstein AöR | Phase III | Recruiting | Dec 2025 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Azathioprine | 1 | Unknown | 2025-12-05 | 2025-12-05 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.